Freeline Therapeutics Holdings plc ADR buy Wedbush
Start price
04.10.23
/
50%
€3.21
Target price
04.10.24
€7.61
Performance (%)
0.00%
End price
05.10.24
-
Summary
This prediction is currently being closed. Wedbush's BUY prediction for Freeline Therapeutics Holdings plc ADR is currently unchanged. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Freeline Therapeutics Holdings plc ADR | - | - | - |
| iShares Core DAX® | -0,68 % | 4,05 % | 2,21 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % | 38,04 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % | 59,00 % |
| iShares S&P 500 | 0,62 % | 6,20 % | 26,15 % |
Comments by Wedbush for this prediction
In the thread Freeline Therapeutics Holdings plc ADR diskutieren
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $8.00 price target on the stock, up previously from $5.00.
Ratings data for FRLN provided by MarketBeat
In the thread Trading Freeline Therapeutics Holdings plc ADR
Die von Wedbush gewählte maximale Laufzeit wurde überschritten